Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ACONW

Aclarion (ACONW)

Aclarion Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACONW
DateTimeSourceHeadlineSymbolCompany
16/05/202405:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACONWAclarion Inc
25/04/202423:14GlobeNewswire Inc.Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back PainNASDAQ:ACONWAclarion Inc
05/03/202400:00GlobeNewswire Inc.Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar DiscsNASDAQ:ACONWAclarion Inc
28/02/202407:22GlobeNewswire Inc.Aclarion Announces Closing of $3.0 Million Public OfferingNASDAQ:ACONWAclarion Inc
27/02/202401:15GlobeNewswire Inc.Aclarion Announces Pricing of $3.0 Million Public OfferingNASDAQ:ACONWAclarion Inc
06/02/202400:00GlobeNewswire Inc.Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic PartnershipNASDAQ:ACONWAclarion Inc
23/01/202400:00GlobeNewswire Inc.Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MDNASDAQ:ACONWAclarion Inc
18/01/202400:00GlobeNewswire Inc.Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan SolutionNASDAQ:ACONWAclarion Inc
09/01/202400:00GlobeNewswire Inc.Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of NociscanNASDAQ:ACONWAclarion Inc
03/01/202404:00GlobeNewswire Inc.Aclarion Announces Reverse Stock SplitNASDAQ:ACONWAclarion Inc
28/11/202300:00GlobeNewswire Inc.Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan ExamsNASDAQ:ACONWAclarion Inc
09/11/202300:00GlobeNewswire Inc.Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan AdoptionNASDAQ:ACONWAclarion Inc
07/11/202300:00GlobeNewswire Inc.Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MDNASDAQ:ACONWAclarion Inc
01/11/202323:00GlobeNewswire Inc.Aclarion Presents at the NIH HEAL Initiative Fall MeetingNASDAQ:ACONWAclarion Inc
25/10/202323:30GlobeNewswire Inc.Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to DenverNASDAQ:ACONWAclarion Inc
24/10/202323:45GlobeNewswire Inc.Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM MeetingNASDAQ:ACONWAclarion Inc
23/10/202322:00GlobeNewswire Inc.Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of NociscanNASDAQ:ACONWAclarion Inc
02/10/202323:00GlobeNewswire Inc.Aclarion Provides Updated Investor Presentation and Corporate UpdateNASDAQ:ACONWAclarion Inc
26/08/202306:10GlobeNewswire Inc.Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly ReportNASDAQ:ACONWAclarion Inc
15/06/202301:27GlobeNewswire Inc.Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MINASDAQ:ACONWAclarion Inc
08/06/202321:30GlobeNewswire Inc.Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual MeetingNASDAQ:ACONWAclarion Inc
30/05/202321:30GlobeNewswire Inc.Aclarion Announces New Engagement with The London Clinic and London Spine ClinicNASDAQ:ACONWAclarion Inc
23/05/202321:30GlobeNewswire Inc.Aclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MDNASDAQ:ACONWAclarion Inc
23/05/202321:00GlobeNewswire Inc.Aclarion, Inc. Announces Delayed 10-Q FilingNASDAQ:ACONWAclarion Inc
19/05/202321:30GlobeNewswire Inc.Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical CatalystsNASDAQ:ACONWAclarion Inc
02/05/202321:00GlobeNewswire Inc.Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial Evaluating Nociscan in the Diagnosis and Treatment of Chronic Low Back PainNASDAQ:ACONWAclarion Inc
29/04/202301:20GlobeNewswire Inc.Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023NASDAQ:ACONWAclarion Inc
24/04/202321:00GlobeNewswire Inc.Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical TrialNASDAQ:ACONWAclarion Inc
08/03/202301:19GlobeNewswire Inc.Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician AdvisorNASDAQ:ACONWAclarion Inc
15/02/202323:00GlobeNewswire Inc.Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine SymposiumNASDAQ:ACONWAclarion Inc
 Showing the most relevant articles for your search:NASDAQ:ACONW

Your Recent History

Delayed Upgrade Clock